Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations.
about
Evaluation of Doravirine Pharmacokinetics When Switching from Efavirenz to Doravirine in Healthy Subjects.Mechanistic Study of Common Non-Nucleoside Reverse Transcriptase Inhibitor-Resistant Mutations with K103N and Y181C SubstitutionsIdentification of novel bifunctional HIV-1 reverse transcriptase inhibitors.Role of phenotypic investigation in the era of routine genotypic HIV-1 drug resistance testing
P2860
Doravirine Suppresses Common Nonnucleoside Reverse Transcriptase Inhibitor-Associated Mutants at Clinically Relevant Concentrations.
description
2016 nî lūn-bûn
@nan
2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Doravirine Suppresses Common N ...... cally Relevant Concentrations.
@ast
Doravirine Suppresses Common N ...... cally Relevant Concentrations.
@en
type
label
Doravirine Suppresses Common N ...... cally Relevant Concentrations.
@ast
Doravirine Suppresses Common N ...... cally Relevant Concentrations.
@en
prefLabel
Doravirine Suppresses Common N ...... cally Relevant Concentrations.
@ast
Doravirine Suppresses Common N ...... cally Relevant Concentrations.
@en
P2093
P2860
P356
P1476
Doravirine Suppresses Common N ...... cally Relevant Concentrations.
@en
P2093
Daria J Hazuda
Jay Grobler
Meizhen Feng
Michael D Miller
Ming-Tain Lai
Nancy A Sachs
Wade Blair
P2860
P304
P356
10.1128/AAC.02650-15
P407
P577
2016-02-01T00:00:00Z